Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk

Three Ebolavirus genus viruses cause lethal disease and lack targeted therapeutics: Ebola virus, Sudan virus and Bundibugyo virus. Monoclonal antibody (mAb) cocktails against the surface glycoprotein (GP) present a potential therapeutic strategy. Here we report two crystal structures of the antibody...

Descripción completa

Detalles Bibliográficos
Autores principales: King, Liam B., West, Brandyn R., Moyer, Crystal L., Gilchuk, Pavlo, Flyak, Andrew, Ilinykh, Philipp A., Bombardi, Robin, Hui, Sean, Huang, Kai, Bukreyev, Alexander, Crowe, James E., Saphire, Erica Ollmann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470140/
https://www.ncbi.nlm.nih.gov/pubmed/30996276
http://dx.doi.org/10.1038/s41467-019-09732-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470140/
https://www.ncbi.nlm.nih.gov/pubmed/30996276
http://dx.doi.org/10.1038/s41467-019-09732-7

Ejemplares similares